Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab

Alexandre Reubena, Mariana Petaccia de Macedob, Jennifer McQuadec, Aron Joond, Zhiyong Rene,Tiffany Calderoneb, Brandy Connerb, Khalida Wanib, Zachary A. Coopera,f,z, Hussein Tawbic, Michael T. Tetzlaffb,e, Robert F. Paderag, Jean-Bernard Durandh, Alexander J. Lazarb,e, Jennifer A. Wargoa,f, and Michael A. Daviesb,c,i aDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; bTranslational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; cMelanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; ePathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; fGenomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; gDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA; hCardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; iSystems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA